181 related articles for article (PubMed ID: 301780)
1. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
2. Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases.
Jaffe N; Frei E; Traggis D; Watts H
Cancer; 1977 Jan; 39(1):45-50. PubMed ID: 299828
[TBL] [Abstract][Full Text] [Related]
3. Osteogenic sarcoma: state of the art with high-dose methotrexate treatment.
Jaffe N
Clin Orthop Relat Res; 1976 Oct; (120):95-102. PubMed ID: 1086179
[TBL] [Abstract][Full Text] [Related]
4. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
[TBL] [Abstract][Full Text] [Related]
5. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
[TBL] [Abstract][Full Text] [Related]
6. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
7. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
[TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate in osteogenic sarcoma.
Jaffe N; Link MP; Cohen D; Traggis D; Frei E; Watts H; Beardsley GP; Abelson HT
Natl Cancer Inst Monogr; 1981 Apr; (56):201-6. PubMed ID: 6975438
[TBL] [Abstract][Full Text] [Related]
9. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
Kotz R; Leber H; Ramach W; Arbes H; Wolf A
Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for osteosarcoma.
Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
Gilchrist GS; Ivins JC; Ritts RE; Pritchard DJ; Taylor WF; Edmonson JM
Cancer Treat Rep; 1978 Feb; 62(2):289-94. PubMed ID: 346219
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-citrovorum factor used alone and in combination chemotherapy for advanced hypernephromas.
Baumgartner G; Heinz R; Arbes H; Lenzhofer R; Pridun N; Schüller J
Cancer Treat Rep; 1980 Jan; 64(1):41-6. PubMed ID: 6155211
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma--the winds of change.
Mills EE
S Afr Med J; 1978 May; 53(18):695-8. PubMed ID: 308700
[TBL] [Abstract][Full Text] [Related]
17. [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients].
Wang QL; Sun Y; Zhou JC; Song SZ; Feng FY; Lu L; Yie ZS
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):152-4. PubMed ID: 3264785
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with metastatic osteogenic sarcoma: a report from the Children's Cancer Study Group.
Morgan E; Baum E; Bleyer WA; Movassaghi N; Provisor A; Lampkin B; Lukens J; Griffin T; White H; Fryer C
Cancer Treat Rep; 1984 Apr; 68(4):661-4. PubMed ID: 6370429
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma.
Pratt CB; Howarth C; Ransom JL; Bowles D; Green AA; Kumar AP; Rivera G; Evans WE
Cancer Treat Rep; 1980 Jan; 64(1):11-20. PubMed ID: 6966535
[TBL] [Abstract][Full Text] [Related]
20. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]